Importantly, TNF-α-driven DC1 activation and protective T cell responses identified one mechanism of the increased susceptibility to cryptococcal and other fungal infection in patients undergoing treatments with TNF-α blockade therapies. This evidence concerns the gene ZDHHC4 and fungal infectious disease.